Data protection Impressum

Life sciences

Backed by its parent company Nanobacterie's fourth-place in nanomedicine patent rankings by Marks and Clerk, AlphaOnco Swiss channels the synergy of Franco-Swiss collaboration to bring forth groundbreaking cancer treatments.

Nanomedicine pioneer Nanobacterie achieves remarkable patent ranking

23 August 2023

Replacing the main building constructed in 1970, the Anna-Seiler-Haus stands out as one of Switzerland's most advanced and appealing hospital buildings.

Inselspital’s CHF 670 million Anna-Seiler-Haus to set new standards in healthcare

21 August 2023

Tau imaging with 18F-Flortaucipir PET in Alzheimer’s disease. The figure shows a prototypical tau accumulation pattern, obtained by comparing tau load of patients with Alzheimer’s disease vs healthy controls. The blue-to-white color scale indicates more pronounced tau loads, with pink-white areas representing those with the highest accumulation.

HUG and UNIGE unveil the next frontier in Alzheimer’s diagnosis

15 August 2023

The canton of Bern, with its continual focus on advancing medicine through research, technology, and collaboration, stands as destination rich in opportunities for companies aiming to grow and innovate in the fields of medicine and life sciences.

Bern’s thriving ecosystem for life sciences innovation

9 August 2023

This discovery provides insight into the complex ecosystem of the tumor microenvironment and offers a new perspective on the treatment of cancer, particularly in the field of oncology.

UNIGE researchers lead breakthrough in understanding tumor growth

8 August 2023

EPITERNA focuses on developing therapies that can extend the healthy lifespan of companion dogs, cats, and humans.

Longevity start-up EPITERNA raises EUR 10 million to slow ageing and extend lifespan

7 August 2023

The EPFL researchers’ novel approach combines multi-limb manipulation with cutting-edge shared control augmentation.

EPFL researchers develop a four-arm robotic-assisted surgery system

11 July 2023

Since its Observer Country status since December 2015, Switzerland has participated in over 20 multinational clinical trials and infrastructure projects under the ECRIN banner, including platform trials on COVID-19.

European clinical research infrastructure bolstered as Switzerland becomes ECRIN member

5 July 2023

EBAMed's solution combines medical devices for proton therapy and motion tracking imaging and software to enable the treatment of patients in a non-invasive way, in a single out-patient session, whilst increasing 5-fold the patient throughput and saving costs.

EBAMed raises EUR 14.35 million to propel its groundbreaking cardiac radiation ablation therapy

4 July 2023

CSEM to establish a digital health research department in Bern

19 June 2023

1 … 25 26 27 28 29 30